Literature DB >> 2853548

Myopia and diabetes. A review.

M Mäntyjärvi1.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 2853548     DOI： 10.1111/j.1755-3768.1988.tb02672.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Suppl


× No keyword cloud information.
  7 in total

1.  Long-term influence of insulin dependent diabetes mellitus on refraction and its components: a population based twin study.

Authors:  N Løgstrup; A K Sjølie; K O Kyvik; A Green
Journal:  Br J Ophthalmol       Date:  1997-05       Impact factor: 4.638

2.  Myopia in young patients with type 1 diabetes mellitus.

Authors:  Swati Handa; Audrey Chia; Hla Myint Htoon; Pin Min Lam; Fabian Yap; Yvonne Ling
Journal:  Singapore Med J       Date:  2015-08       Impact factor: 1.858

Review 3.  Genetic and environmental effects on myopia development and progression.

Authors:  E Goldschmidt; N Jacobsen
Journal:  Eye (Lond)       Date:  2013-12-20       Impact factor: 3.775

4.  Nine-year refractive changes in the Barbados Eye Studies.

Authors:  Suh-Yuh Wu; Yun Joo Yoo; Barbara Nemesure; Anselm Hennis; M Cristina Leske
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-11       Impact factor: 4.799

5.  Higher HbA1c may reduce axial length elongation in myopic children: a comparison cohort study.

Authors:  Chun-Fu Liu; Shin-Chieh Chen; Fu-Sung Lo; Nan-Kai Wang; Kuan-Jen Chen; Laura Liu; Yen-Po Chen; Eugene Yu-Chuan Kang; Pei-Kang Liu; Ling Yeung; Wei-Chi Wu; Chi-Chun Lai
Journal:  Acta Diabetol       Date:  2021-02-15       Impact factor: 4.087

6.  Refractive properties of the healthy human eye during acute hyperglycemia.

Authors:  Nanouk G M Wiemer; Elisabeth M W Eekhoff; Suat Simsek; Robert J Heine; Peter J Ringens; Bettine C P Polak; Michiel Dubbelman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-04       Impact factor: 3.117

7.  Novel Myopia Genes and Pathways Identified From Syndromic Forms of Myopia.

Authors:  D Ian Flitcroft; James Loughman; Christine F Wildsoet; Cathy Williams; Jeremy A Guggenheim
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.